Connect Sign In
April 29, 2024ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs.
November 29, 2023ARUP believes the FDA’s plan to regulate lab-developed tests will limit access to testing, increase costs, and face a court challenge, and is calling for collaboration to better address LDT oversight.
October 2, 2023The FDA’s newly proposed rules would regulate all in vitro diagnostic products as medical devices if enacted. ARUP believes additional FDA oversight would disrupt the diagnostic testing market.
September 29, 2023New ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ will improve patient lives by advancing groundbreaking diagnostic and prognostic technologies.
March 20, 2024ARUP’s new test, Alzheimer’s Disease Markers, CSF, will pave the way for more assays that help detect the disease soon enough to try therapy to slow its progression.
March 5, 2024Nearly 85% of respondents to an ARUP survey believe the FDA’s proposed rule to regulate lab-developed tests will negatively impact their labs. Only 3% believe they have the financial resources to
April 26, 2024Nicola Longo, who with his wife, Marzia Pasquali, is credited with expanding screening for a treatable metabolic disorder, is leaving for UCLA while Pasquali stays at ARUP to continue key projects.
May 30, 2024
ARUP Files Declaration to Support Lawsuit Challenging the FDA's Rule to Regulate Lab-Developed Tests
ARUP’s declaration amplifies the lawsuit’s claims that the FDA does not have legal authority over laboratory testing services and that regulating these services is unreasonable.April 24, 2024A new partnership between ARUP and connectivity provider ELLKAY aims to give health systems the testing support, guidance, and technology needed to establish or expand lab outreach operations.
July 5, 2023The FDA now recommends the same assessment questions for all donors, regardless of gender or sexual orientation. ARUP Blood Services is one of the first donor centers to update processes in response.
January 10, 2024After wrapping up her education in plant biology, Dipanwita Banerjee, MS, took some time off to see the world and start a family. She later returned to the laboratory environment at ARUP.
December 1, 2023Utah Business magazine honored ARUP Laboratories with its Best Companies to Work For award for the sixth consecutive year based on anonymous employee survey results.
August 22, 2023Forbes magazine has listed ARUP as one of the 2023 Best Employers by State based on employer recommendations from employees and others in Utah in a recent survey conducted by Statista.
August 15, 2023ARUP is gearing up for the launch of a new hematopathology webinar to be hosted by Madhu Menon, MD, PhD, FCAP. Other ARUP experts will join Menon to discuss timely issues in hematopathology testing.
November 10, 2023
EU Approval of AAV5 DetectCDx™ Provides Access to Companion Diagnostic for Hemophilia A Gene Therapy
ARUP has gained a Conformité Européenne (CE) mark for AAV5 DetectCDx™ single-site use. The test will aid in determining the eligibility of non-U.S. patients for a new hemophilia A gene therapy.November 10, 2023A panel discussion at the Utah Life Sciences Summit explored how the FDA’s proposed rule to further regulate laboratory-developed tests could slow advances in diagnostic medicine.
February 22, 2024The MenoCheck test helps providers treat women who are experiencing menopausal transition and manage the health risks associated with decreased estrogen production.
March 21, 2024The FDA’s proposed rule to regulate lab-developed tests will force labs to halt essential testing, harming children and patients with cancer and rare diseases, says ARUP’s Jonathan Genzen, MD, PhD.
